The AFR ancestry showed the highest proportion of TMB-high cases in the overall cohort (41%) as well as in KRAS- (42%) and EGFR-altered (18%) non-Sq NSCLC. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.